News
James Bennett-Levy will be leading a world's first trial investigating MDMA and therapy to treat PTSD.
May 3rd 2024
Southern Cross University in Lismore, NSW, has launched a four-year clinical trial to support people with PTSD related to the devastating 2017 and 2022 floods in the Northern Rivers region. The trial, backed by $3.8 million in public funding, will recruit 200-250 participants for a stepped-care model involving compassion-focused arts programs and MDMA-assisted psychedelic therapy.